Sustained release formulation

Details Sustained release formulation Sustained release formulation

A - Human Necessities

61

K

A61K 47/36 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01) A61K 47/26 (2006.01) A61K 47/42 (2006.01)

Patent

CA 2217134

The present invention relates to a sustained release formulation used for treatment or prevention of the diseases, which contains a therapeutically effective substance as an active ingredient, collagen as a drug carrier, and glycosaminoglycan as an additive. The formulation allows controlled release of the therapeutically effective substance.

L'invention porte sur une formulation à libération-retard pour le traitement ou la prévention de maladies; elle contient une substance thérapeutique comme ingrédient actif, du collagène comme véhicule pour le médicament, et du glycosaminoglycane comme additif. La formulation permet de prolonger la libération de la substance thérapeutique.

Affiliated with

Also associated with

Rating

Sustained release formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1470985